Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Beattie; David
Address:
Horsham, GB
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8283362 Beta-2-adrenoreceptor agonists October 9, 2012
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
8273900 Organic compounds September 25, 2012
There are described cyclohexyl amide derivatives useful as corticotropin releasing factor (CRF.sub.1) receptor antagonists.
8067437 Beta-2-adrenoreceptor agonists November 29, 2011
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7820694 Beta-2-adrenoreceptor agonists October 26, 2010
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7745462 Quinoline-2-one derivatives for the treatment of airways diseases June 29, 2010
Compounds of formula I ##STR00001## in free or salt form, wherein --C--Y--, R.sup.1 and R.sup.2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the .beta..sub.2-adrenoreceptor. Pharmaceut
7622483 .beta.2-adrenoceptor agonists November 24, 2009
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
6921757 Organic compounds July 26, 2005
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals ##STR1##
6878721 Beta2-adrenoceptor agonists April 12, 2005
Compounds of formula ##STR1##in free or salt or solvate form, where Ar is a group of formula ##STR2##Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their p










 
 
  Recently Added Patents
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
Methods for measuring media performance associated with adjacent track interference
Flexible lighting devices
Apparatus with a local timing circuit that generates a multi-phase timing signal for a digital signal processing circuit
Semiconductor chip, stack module, and memory card
Unified recovery
Mobile device case with storage compartment
  Randomly Featured Patents
Ring-alkylated m-phenylene diamine blends for use in curing epoxy resins
Electrical junction box
Purification of von Willebrand factor by affinity chromatography
Stackable flex circuit chip package and method of making same
Techniques to manage a relay server and a network address translator
Southern highbrush blueberry plant named `FLX-2`
Method for producing a fatty alcohol or fatty aldehyde
Process for making an array of tapered photopolymerized waveguides
Bow tying apparatus and method of use
Moisture-impervious panel capable of delayed hydration